IPMA
GO

Categories


Cart Summary

Your shopping cart is empty.
Product Qty Amount
From:
Until:

Best Practices: Pain Management & Opioid Prescribing

CE/CME: 2.5
Meets Opioid Prescribing Requirements in Most States
Effective Date:  May 24, 2023
Expiration Date: May 24, 2024

General Description
Deaths from drug overdoses have increased in the nation driven in part by addiction to prescription painkillers and heroin.  This education is meant to help providers make informed decisions about prescribing opioids for acute and chronic pain while encouraging the implementation of best practices for responsible opioid prescribing.  Education developed by IPMA will meet Wisconsin and Minnesota’s educational requirements and will be delivered to prescribers and their health care team. 

Credit
This activity was planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME).  The Interstate Postgraduate Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designations
The Interstate Postgraduate Medical Association designates this enduring activity for a maximum 2.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CE activity meets the SAMHSA/DEA expectations and can be used to fulfill the MATE Act requirement for prescribers.

Commercial Support
None

$60.00

Deaths from drug overdoses have increased in the nation driven in part by addiction to prescription painkillers and heroin.  This education is meant to help providers make informed decisions about prescribing opioids for acute and chronic pain while encouraging the implementation of best practices for responsible opioid prescribing.  Learning objectives:

  • Apply best practices in pain management in acute, chronic, and post-operative pain including the focus on function and on non-pharmacologic interventions for pain
  • Discuss implantable device alternatives for treatment of ongoing pain
  • Adopt and utilize best practices in opioid prescribing
  • Identify factors that increase and decrease mortality in patients being prescribed opioids and prescribe naloxone for at risk patients
  • Identify, treat, and/or refer for management of addiction and opioid use disorder
  • Develop an individualized tapering plan for those on chronic opioids

Target Learners

This activity is designed for clinicians who prescribe controlled substances.

Credit

This activity was planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME).  The Interstate Postgraduate Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designations

The Interstate Postgraduate Medical Association designates this live activity for a maximum 2.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This education meets the Wisconsin Medical Examining Board's emergency rule relating to continuing medical education on its opioid prescribing guideline.  This CE activity meets the SAMHSA/DEA expectations and can be used to fulfill the MATE Act

Disclosure Information
As a provider dedicated to independent education and accredited by the ACCME, IPMA must ensure balance, independence, objectivity, scientific rigor, and integrity in all its educational activities. All individuals with potential to influence the content of this program have disclosed all financial relationships that have occurred in the past 24 months with ineligible companies.  The disclosures have been reviewed according to policy. All individuals with potential conflicts have been contacted as needed by IPMA staff, and issues of conflict have been discussed, managed, and mitigated.  All individuals with the ability to influence the content of this educational activity have no relevant financial relationships with ineligible companies to disclose.

Disclaimer
The opinions expressed in the enduring educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Privacy Policy
At IPMA, we care about providing you with tools and information to manage and protect your online privacy. IPMA retains records solely for keeping records in accordance with ACCME policies. We will not share your information with any other organizations. We will keep you informed of our CME activities. Please e-mail cmehelp@ipmameded.org if you do not want to receive any communications from us.

Commercial Support
None